RENAISSANCE TECHNOLOGIES LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1037389 NEW YORK, NY

Position in CRBP

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,258,311

+$374,309 QoQ

Shares Held

346,998

-2.1% QoQ

Ownership

1.87%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. CRBP ranks #107 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,258,311	346,998	-2.1%	Shares	Sole	2026-05-14
2025-12-31	$2,884,002	354,300	+230.5%	Shares	Sole	2026-02-12
2025-09-30	$1,356,080	107,200	-30.2%	Shares	Sole	2025-11-13
2025-06-30	$1,059,419	153,539	-55.5%	Shares	Sole	2025-08-13
2025-03-31	$1,833,012	345,200	+148.2%	Shares	Sole	2025-05-14
2024-12-31	$1,641,380	139,100	+769.4%	Shares	Sole	2025-02-13
2024-09-30	$330,080	16,000	+58.1%	Shares	Sole	2024-11-13
2024-03-31	$397,226	10,123	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.